Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 2
2008 4
2009 3
2010 9
2011 4
2012 8
2013 17
2014 19
2015 22
2016 11
2017 12
2018 9
2019 10
2020 20
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yanming du (34 results)?
Prospects for a MERS-CoV spike vaccine.
Zhou Y, Jiang S, Du L. Zhou Y, et al. Among authors: du l. Expert Rev Vaccines. 2018 Aug;17(8):677-686. doi: 10.1080/14760584.2018.1506702. Epub 2018 Aug 9. Expert Rev Vaccines. 2018. PMID: 30058403 Free PMC article. Review.
MERS-CoV spike protein: a key target for antivirals.
Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S. Du L, et al. Expert Opin Ther Targets. 2017 Feb;21(2):131-143. doi: 10.1080/14728222.2017.1271415. Epub 2016 Dec 21. Expert Opin Ther Targets. 2017. PMID: 27936982 Free PMC article. Review.
Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.
Zeng LP, Ge XY, Peng C, Tai W, Jiang S, Du L, Shi ZL. Zeng LP, et al. Among authors: du l. Sci China Life Sci. 2017 Dec;60(12):1399-1402. doi: 10.1007/s11427-017-9189-3. Epub 2017 Nov 10. Sci China Life Sci. 2017. PMID: 29134417 Free PMC article. No abstract available.
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.
Xia S, Yan L, Xu W, Agrawal AS, Algaissi A, Tseng CK, Wang Q, Du L, Tan W, Wilson IA, Jiang S, Yang B, Lu L. Xia S, et al. Among authors: du l. Sci Adv. 2019 Apr 10;5(4):eaav4580. doi: 10.1126/sciadv.aav4580. eCollection 2019 Apr. Sci Adv. 2019. PMID: 30989115 Free PMC article.
Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, Ying T, Lu L, Jiang S. Xia S, et al. Among authors: du l. Virus Res. 2014 Dec 19;194:200-10. doi: 10.1016/j.virusres.2014.10.007. Epub 2014 Oct 14. Virus Res. 2014. PMID: 25451066 Free PMC article. Review.
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.
Wang N, Shang J, Jiang S, Du L. Wang N, et al. Among authors: du l. Front Microbiol. 2020 Feb 28;11:298. doi: 10.3389/fmicb.2020.00298. eCollection 2020. Front Microbiol. 2020. PMID: 32265848 Free PMC article. Review.
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y, Yang Y, Huang J, Jiang S, Du L. Zhou Y, et al. Among authors: du l. Viruses. 2019 Jan 14;11(1):60. doi: 10.3390/v11010060. Viruses. 2019. PMID: 30646569 Free PMC article. Review.
Development of SARS vaccines and therapeutics is still needed.
Jiang S, Lu L, Du L. Jiang S, et al. Among authors: du l. Future Virol. 2013 Jan;8(1):1-2. doi: 10.2217/fvl.12.126. Epub 2012 Dec 20. Future Virol. 2013. PMID: 32201503 Free PMC article. No abstract available.
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.
Jiang S, Hillyer C, Du L. Jiang S, et al. Among authors: du l. Trends Immunol. 2020 May;41(5):355-359. doi: 10.1016/j.it.2020.03.007. Epub 2020 Apr 2. Trends Immunol. 2020. PMID: 32249063 Free PMC article.
139 results
Jump to page
Feedback